Mangalam Organics Ltd (MANORG) AI Stock Analysis

• Market Cap: ₹4.31B
• Dividend Yield: N/A
• Average Volume (3M): 489.00
• Price to Earnings (P/E): 18.6
• Beta (1Y): 0.97
• Revenue Growth: 11.14%
• EPS Growth: 309.69%
• Country: IN
• Employees: 307
• Sector: Basic Materials
• Sector Strength: 58
• Industry: Chemicals - Specialty
• EPS (TTM): 14.28
• Shares Outstanding: 8,564,440
• 10 Day Avg. Volume: 561
• 30 Day Avg. Volume: 489
• PEG Ratio: 0.14
• Price to Book (P/B): 1.08
• Price to Sales (P/S): 0.60
• P/FCF Ratio: -4.22
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: ₹573.00
• Price Target Upside: 13.83% Upside
• Rating Consensus: Hold
• Number of Analyst Covering: 1

• Rating: 57 Neutral
• Price Target: ₹573.00 ▲(13.83% Upside)

Mangalam Organics' overall stock score is primarily impacted by its financial performance, which shows revenue growth but weak profitability and cash flow. Technical analysis indicates bearish momentum, and valuation suggests moderate pricing. The absence of earnings call data and corporate events means these factors do not influence the score.

Mangalam Organics Ltd Business Overview & Revenue Model

Company Description

Mangalam Organics Ltd (MANORG) is a leading player in the specialty chemicals sector, primarily focusing on the production of a diverse range of organic chemicals and fine chemicals. The company is known for its commitment to sustainable practices and innovation, catering to various industries including pharmaceuticals, agrochemicals, and personal care. With a robust manufacturing infrastructure and a dedicated team, Mangalam Organics aims to deliver high-quality products that meet the evolving needs of its global clientele.

How the Company Makes Money

Mangalam Organics generates revenue primarily through the sale of its specialty chemicals, which serve as essential intermediates for various end-use applications in pharmaceuticals, agrochemicals, and other industries. The company's revenue model is based on direct sales to manufacturers and distributors, allowing for consistent cash flow from both domestic and international markets. Key revenue streams include bulk orders from large-scale industrial clients as well as smaller contracts with niche firms requiring specialized chemical solutions. Additionally, strategic partnerships with research and development organizations enhance its product offerings and market reach, contributing significantly to its financial performance.

Mangalam Organics Ltd Financial Statement Overview

Summary

Mangalam Organics shows positive revenue growth and operational efficiency improvements, yet profitability and cash flow generation remain weak. The balance sheet reflects moderate leverage and stability, but the low return on equity and negative cash flow trends pose risks. Strategic focus on enhancing profitability and cash flow is essential to strengthen financial health.

Income Statement

Mangalam Organics exhibited a strong revenue growth of 7.39% from 2024 to 2025, with an improved gross profit margin of 48.40% in 2025, up from 22.89% in 2024. However, the net profit margin remains low at 2.38% due to increased expenses, limiting profitability. The EBIT and EBITDA margins also show improvement, indicating efficient operations despite the low net income.

Balance Sheet

The company has a moderate debt-to-equity ratio of 0.93 in 2025, indicating a balanced use of debt and equity. The return on equity (ROE) is low at 4.29%, reflecting limited profitability relative to shareholder investment. The equity ratio is satisfactory at 47.02%, suggesting a stable financial structure but highlighting potential risks if profits do not improve.

Cash Flow

Cash flow performance is concerning, with negative free cash flow growth of -329.40% from 2024 to 2025. Operating cash flow turned negative, indicating cash generation issues. The operating cash flow to net income ratio is negative, suggesting operational inefficiencies. These factors pose a risk to liquidity and future investment capability.

Breakdown	TTM	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Income Statement
Total Revenue	5.59B	5.30B	4.94B	4.93B	4.91B	3.38B
Gross Profit	2.89B	2.57B	1.13B	701.20M	1.47B	1.72B
EBITDA	734.82M	589.13M	390.38M	-24.27M	924.25M	1.28B
Net Income	231.55M	125.97M	42.86M	-272.25M	537.43M	847.79M
Balance Sheet
Total Assets	0.00	6.24B	4.85B	5.06B	5.60B	3.11B
Cash, Cash Equivalents and Short-Term Investments	10.10M	189.27M	20.19M	12.79M	12.78M	343.55M
Total Debt	0.00	2.72B	1.73B	1.90B	2.12B	243.11M
Total Liabilities	-2.93B	3.30B	2.05B	2.30B	2.56B	596.26M
Stockholders Equity	2.93B	2.93B	2.81B	2.76B	3.04B	2.52B
Cash Flow
Free Cash Flow	0.00	-751.15M	327.48M	361.57M	-1.84B	-27.60M
Operating Cash Flow	0.00	-78.44M	727.23M	769.23M	-841.04M	262.79M
Investing Cash Flow	0.00	-670.47M	-395.09M	-407.80M	-995.25M	-281.47M
Financing Cash Flow	0.00	736.26M	-325.52M	-355.77M	1.83B	22.66M

Mangalam Organics Ltd Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 503.40
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Positive
• MACD: Positive
• RSI: Neutral
• STOCH: Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:MANORG, the sentiment is Negative. The current price of 503.4 is below the 20-day moving average (MA) of 529.99, below the 50-day MA of 547.96, and above the 200-day MA of 486.72, indicating a neutral trend. The MACD of -13.90 indicates Positive momentum. The RSI at 37.86 is Neutral, neither overbought nor oversold. The STOCH value of 13.39 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IN:MANORG.

Mangalam Organics Ltd Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
INTLCONV	81 Outperform	₹6.20B	5.54	―	0.77%	11.59%	39.65%
AARTISURF	63 Neutral	₹3.86B	25.31	―	0.22%	25.15%	-16.43%
MAHASTEEL	62 Neutral	₹9.24B	109.15	―	―	2.99%	45.22%
Sector *	61 Neutral	$10.43B	7.12	-0.05%	2.87%	2.86%	-36.73%
MANGALAM	58 Neutral	₹1.11B	19.78	―	―	-16.39%	-410.09%
MANORG	57 Neutral	₹4.31B	18.62	―	―	11.14%	309.69%